Erectile dysfunction. Impotence of organic origin
Conditions
Interventions
Intervention 1: Atorvastatin 40 mg/day and Sildenafil 100 mg before every intercourse. Intervention 2: Placebo with the same dose and shaoe as Atorvastatin and Sildenafil 100 mg before every intercour
Treatment - Drugs
Atorvastatin 40 mg/day and Sildenafil 100 mg before every intercourse
Placebo with the same dose and shaoe as Atorvastatin and Sildenafil 100 mg before every intercourse
Sponsors
Urology and Nephrology Research Center ( UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: Presence of erectile dysfunction and without a proper response to the Sildenafil treatment, Exclusion criteria: Receiving nitrate drugs, high serum lipids (LDL>130, Cholestrol >200), Receiving Statin drugs, Acute coronary accidents in the 6 month prior to study, severe and uncontrolled diabetes mellitus, active thyroid disease, mental disorder or depression diagnosed by a psychiatrist, prostate surgery history with the consequent ED, active liver disease, renal failure (cr>2)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erectile dysfunction. Timepoint: Baseline and 6 and 12 weeks after treatment. Method of measurement: IIEF-5 questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual ability. Timepoint: Baseline and 6 and 12 weeks after treatment. Method of measurement: IIEF-5 ? GEQ questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Alireza Lasheie
Urology and Nephrology Research Center ( UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran, I.R
Outcome results
None listed